Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole plus gonadotropin in IVF/ICSI
IRCT20120104008611N12Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2021
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of letrozole, menotropins, human chorionic gonadotropin and gonadotropin-releasing hormone agonist in infertility and endometriosis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Cinnal-f dosage, HMG dosage and 6 more. Started Apr 2021; status: completed.
02
Drugs
letrozolemenotropinshuman chorionic gonadotropingonadotropin-releasing hormone agonist
03
Conditions
infertilityendometriosis
Beyond the preview
Go deeper on IRCT20120104008611N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120104008611N12.